Skip to main content

Table 1 Shows reported use of specific treatments for JLS by clinician group

From: PReS-FINAL-2119: United Kingdom survey of current management of juvenile localised scleroderma

Treatment Used Reported use by prs (% of respondents) Reported use by dms (% of respondents)
Topical treatments
Systemic steroids
Ultraviolet light
Methotrexate
Ciclosporin
Hydroxychloroquine
Anti-TNF
Mycophenolate mofetil
Cyclophosphamide
10
90
0
100
30
40
60
90
30
100
79
68
96
32
11
4
18
0